![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif)
| Anticuerpo monoclonal que se une a CD3 (una sustancia que se encuentra en las células T) y que está en estudio para el tratamiento de la enfermedad de injerto contra huésped (GVDH, por sus siglas en inglés). Es un tipo de anticuerpo monoclonal. |
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081102235351im_/http://www.nci.nih.gov/images/spacer.gif) |